Dr. Ira S. Winer
Claim this profileKarmanos Cancer Institute
Area of expertise
Ovarian Cancer
Ira S. Winer has run 12 trials for Ovarian Cancer. Some of their research focus areas include:
Endometrial Cancer
Ira S. Winer has run 6 trials for Endometrial Cancer. Some of their research focus areas include:
Affiliated Hospitals
Karmanos Cancer Institute
Wayne State University/Karmanos Cancer Institute
Clinical Trials Ira S. Winer is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
ONC201 + Paclitaxel
for Ovarian Cancer
This phase II trial studies the side effects of ONC201 and paclitaxel and how well they work in treating patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent), or that does not respond to treatment (refractory). ONC201 is the first in its class of drugs that antagonize some specific cell receptors on cancer cells, leading to their destruction. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ONC201 and paclitaxel may work better in treating patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer compared to paclitaxel alone.
Recruiting
1 award
Phase 2
9 criteria
More about Ira S. Winer
Clinical Trial Related
3 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 11 Active Clinical Trials
Treatments Ira S. Winer has experience with
- Paclitaxel
- Carboplatin
- Biospecimen Collection
- ASk Questions In GYnecologic Oncology (ASQ-GYO) Question Prompt List
- ONC201
- PRO1184
Breakdown of trials Ira S. Winer has run
Ovarian Cancer
Endometrial Cancer
Fallopian Tube Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ira S. Winer specialize in?
Ira S. Winer focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Ira S. Winer currently recruiting for clinical trials?
Yes, Ira S. Winer is currently recruiting for 11 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Ira S. Winer has studied deeply?
Yes, Ira S. Winer has studied treatments such as Paclitaxel, Carboplatin, Biospecimen Collection.
What is the best way to schedule an appointment with Ira S. Winer?
Apply for one of the trials that Ira S. Winer is conducting.
What is the office address of Ira S. Winer?
The office of Ira S. Winer is located at: Karmanos Cancer Institute, Detroit, Michigan 48085 United States. This is the address for their practice at the Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.